
### [MONDO:0015911](http://purl.obolibrary.org/obo/MONDO_0015911)
**Label:** rare acquired hemolytic anemia

**Subclasses:** [MONDO:0020108](http://purl.obolibrary.org/obo/MONDO_0020108) (autoimmune hemolytic anemia), [MONDO:0018641](http://purl.obolibrary.org/obo/MONDO_0018641) (paroxysmal nocturnal hemoglobinuria), [MONDO:0017163](http://purl.obolibrary.org/obo/MONDO_0017163) (hemolytic disease due to fetomaternal alloimmunization), [MONDO:0016450](http://purl.obolibrary.org/obo/MONDO_0016450) (autoimmune hemolytic anemia, cold type), 

**Corr. equiv. classes:** [Orphanet:98375](http://www.orpha.net/ORDO/Orphanet_98375), [Orphanet:228312](http://www.orpha.net/ORDO/Orphanet_228312), [Orphanet:447](http://www.orpha.net/ORDO/Orphanet_447), [Orphanet:275938](http://www.orpha.net/ORDO/Orphanet_275938), 

**Class expressions from DL-Learner:**

- [HP:0001907](http://purl.obolibrary.org/obo/HP_0001907) (Thromboembolism) and [HP:0100724](http://purl.obolibrary.org/obo/HP_0100724) (Hypercoagulability) 62.50%
- [HP:0001907](http://purl.obolibrary.org/obo/HP_0001907) (Thromboembolism) and [HP:0100545](http://purl.obolibrary.org/obo/HP_0100545) (Arterial stenosis) 62.50%
- [HP:0001907](http://purl.obolibrary.org/obo/HP_0001907) (Thromboembolism) and [HP:0030875](http://purl.obolibrary.org/obo/HP_0030875) (Abnormality of pulmonary circulation) 62.50%
- [HP:0001907](http://purl.obolibrary.org/obo/HP_0001907) (Thromboembolism) and [HP:0030680](http://purl.obolibrary.org/obo/HP_0030680) (Abnormality of cardiovascular system morphology) 62.50%
- [HP:0001907](http://purl.obolibrary.org/obo/HP_0001907) (Thromboembolism) and [HP:0030163](http://purl.obolibrary.org/obo/HP_0030163) (Abnormal vascular physiology) 62.50%
- [HP:0001907](http://purl.obolibrary.org/obo/HP_0001907) (Thromboembolism) and [HP:0025270](http://purl.obolibrary.org/obo/HP_0025270) (Abnormality of esophagus physiology) 62.50%
- [HP:0001907](http://purl.obolibrary.org/obo/HP_0001907) (Thromboembolism) and [HP:0025015](http://purl.obolibrary.org/obo/HP_0025015) (Abnormal vascular morphology) 62.50%
- [HP:0001907](http://purl.obolibrary.org/obo/HP_0001907) (Thromboembolism) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 62.50%
- [HP:0001907](http://purl.obolibrary.org/obo/HP_0001907) (Thromboembolism) and [HP:0012492](http://purl.obolibrary.org/obo/HP_0012492) (Cerebral artery stenosis) 62.50%
- [HP:0001907](http://purl.obolibrary.org/obo/HP_0001907) (Thromboembolism) and [HP:0012378](http://purl.obolibrary.org/obo/HP_0012378) (Fatigue) 62.50%
- [HP:0001907](http://purl.obolibrary.org/obo/HP_0001907) (Thromboembolism) and [HP:0012211](http://purl.obolibrary.org/obo/HP_0012211) (Abnormal renal physiology) 62.50%
- [HP:0001907](http://purl.obolibrary.org/obo/HP_0001907) (Thromboembolism) and [HP:0012145](http://purl.obolibrary.org/obo/HP_0012145) (Abnormality of multiple cell lineages in the bone marrow) 62.50%
- [HP:0001907](http://purl.obolibrary.org/obo/HP_0001907) (Thromboembolism) and [HP:0011895](http://purl.obolibrary.org/obo/HP_0011895) (Anemia due to reduced life span of red cells) 62.50%
- [HP:0001907](http://purl.obolibrary.org/obo/HP_0001907) (Thromboembolism) and [HP:0011804](http://purl.obolibrary.org/obo/HP_0011804) (Abnormality of muscle physiology) 62.50%
- [HP:0001907](http://purl.obolibrary.org/obo/HP_0001907) (Thromboembolism) and [HP:0011793](http://purl.obolibrary.org/obo/HP_0011793) (Neoplasm by anatomical site) 62.50%


